1-4 of 4
Qian Wang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Response to BRAF-targeted Therapy Is Enhanced by Cotargeting VEGFRs or WNT/β-Catenin Signaling in BRAF-mutant Colorectal Cancer Models

Khanh B. Tran, Sharada Kolekar, Qian Wang, Jen-Hsing Shih, Christina M. Buchanan, Sanjeev Deva, Peter R. Shepherd
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2022) 21 (12): 1777–1787.
https://doi.org/10.1158/1535-7163.MCT-21-0941
Published: 02 December 2022
View article titled, Response to BRAF-targeted Therapy Is Enhanced by Cotargeting VEGFRs or WNT/β-Catenin Signaling in BRAF-mutant Colorectal Cancer Models
Open the PDF for Response to BRAF-targeted Therapy Is Enhanced by Cotargeting VEGFRs or WNT/β-Catenin Signaling in BRAF-mutant Colorectal Cancer Models in another window
Includes: Supplementary data
Journal Articles

A Combination of BRD4 and HDAC3 Inhibitors Synergistically Suppresses Glioma Stem Cell Growth by Blocking GLI1/IL6/STAT3 Signaling Axis

Qian Wang, Shengnan Jia, Ding Wang, Xuyang Chen, Dhan V. Kalvakolanu, Hongwu Zheng, Xiaodong Wei, Naiyan Wen, Hang Liang, Baofeng Guo, Ling Zhang
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2020) 19 (12): 2542–2553.
https://doi.org/10.1158/1535-7163.MCT-20-0037
Published: 02 December 2020
View article titled, A Combination of BRD4 and HDAC3 Inhibitors Synergistically Suppresses Glioma Stem Cell Growth by Blocking GLI1/IL6/STAT3 Signaling Axis
Open the PDF for A Combination of BRD4 and HDAC3 Inhibitors Synergistically Suppresses Glioma Stem Cell Growth by Blocking GLI1/IL6/STAT3 Signaling Axis in another window
Includes: Supplementary data
Journal Articles

Abstract B14: Targeting amino acid transport to block mTORC1 and cell cycle in prostate cancer

Qian Wang, Rae-Anne Hardie, Andrew Hoy, Ladan Fazli, Charles Bailey, John EJ Rasko, Jeff Holst
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (7_Supplement): B14.
https://doi.org/10.1158/1538-8514.PI3K14-B14
Published: 06 July 2015
View article titled, Abstract B14: Targeting amino acid transport to block mTORC1 and cell cycle in prostate cancer
Journal Articles

Abstract C106: Discovery and characterization of INCB024360, a potent and selective inhibitor of indoleamine 2,3‐dioxygenase (IDO1) as a novel agent for cancer immunotherapy

Xiangdong Liu, Niu Shin, Holly Koblish, Gengjie Yang, Qian Wang, Kathy Wang, Lynn Leffet, Beth Thomas, Mark Rupar, Paul Waeltz, Kevin Bowman, Richard Sparks, Eddy Yue, Yanlong Li, Richard Wynn, Jordan Fridman, Timothy Burn, Andrew Combs, Robert Newton, Peggy Scherle
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): C106.
https://doi.org/10.1158/1535-7163.TARG-09-C106
Published: 10 December 2009
View article titled, Abstract C106: Discovery and characterization of INCB024360, a potent and selective inhibitor of indoleamine 2,3‐dioxygenase (IDO1) as a novel agent for cancer immunotherapy